CHIJIOKE UKOHA

Allopathic & Osteopathic Physicians|Internal Medicine MESQUITE, TX NPI 1124066634

General Payments — all program years on this page

$1,900.01

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 107
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $345.61 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $345.6118

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $30.762
2019 $127.208
2020 $286.9317
2021 $468.2228
2022 $216.2014
2023 $425.0920
2024 $345.6118

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104542068 AstraZeneca Pharmaceuticals LP $18.85 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105515443 AstraZeneca Pharmaceuticals LP $15.20 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105708832 AstraZeneca Pharmaceuticals LP $14.42 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105815383 AstraZeneca Pharmaceuticals LP $15.41 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117880928 Boehringer Ingelheim Pharmaceuticals, Inc. $20.22 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117880930 Boehringer Ingelheim Pharmaceuticals, Inc. $21.63 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117880932 Boehringer Ingelheim Pharmaceuticals, Inc. $22.92 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117880934 Boehringer Ingelheim Pharmaceuticals, Inc. $23.08 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117880936 Boehringer Ingelheim Pharmaceuticals, Inc. $25.24 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117880938 Boehringer Ingelheim Pharmaceuticals, Inc. $27.03 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117880940 Boehringer Ingelheim Pharmaceuticals, Inc. $27.20 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117880942 Boehringer Ingelheim Pharmaceuticals, Inc. $19.04 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132015400 PFIZER INC. $22.57 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136097752 Lilly USA, LLC $16.74 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144590284 Xeris Pharmaceuticals, Inc. $13.09 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153291527 Dexcom, Inc. $15.38 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153291529 Dexcom, Inc. $13.66 11/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153591172 Salix Pharmaceuticals, a division of Bausch Health US, LLC $13.93 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.